The role of antiviral drugs in the treatment of dengue fever has been limited, but is currently widely studied. Focusing on the natural characteristics of dengue, this acute febrile illness can be ...

Brazilian Health Authorities widened the age range of potential recipients of the dengue vaccine as many doses were ...

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

Dengue fever is a disease spread by the vector called Aedes mosquito, which breeds on still water that gets collected especially after the end of the summer. It is primarily transmitted by the ...

Island Pharmaceuticals has completed subject dosing for the phase 2b therapeutic arm of its phase 2a/b PROTECT clinical trial ...

The drug, produced by the laboratory Takeda, targets “dengue virus 2” and protects ... and Medical Technology (Anmat) approved the treatment which is already available at private vaccination ...

In severe cases, dengue can be fatal. Dengue is treated with pain medicine as there is no specific treatment currently. Therefore people should be aware of the risks of dengue fever.  According to the ...

for the treatment of dengue in adults above 18 years old. The SEC, which looked into requests on antimicrobial and antiviral drugs in a meeting held recently, said that after detailed deliberation, it ...

The ongoing research on antiviral drugs might be the clue to better treatment. Dengue has become a widespread infection over the past few year, extending from endemic to nonendemic areas.